Isogenica CSO Guy Hermans presenting at Discovery on Target

 

Meet the Isogenica team at the Discovery on Target 2019 conference, taking place in Boston, 16th-19th September 2019.

 

Dr. Guy Hermans (CSO), will be presenting a talk about the efficient discovery of single domain antibodies to membrane proteins using our synthetic library. The talk will describe the benefits this library design brings, and illustrate some of the unique benefits of VHH technology over conventional antibodies. Recently generated new data will demonstrate how the unbiased diversity enables rapid and resource efficient isolation of developable VHH leads to membrane proteins. Examples will include the use of the library in a phenotypic screening ‘whole cell’ panning project, as well as in selections to isolated membrane proteins complexes.

 

CEO Emma Sceats will also be in attendance. Isogenica welcomes to chance to speak to attendees at the meeting to learn more about their discovery pipelines. Contact This email address is being protected from spambots. You need JavaScript enabled to view it. for partnering meetings.

 

VHH antibodies as biotherapeutics

 

VHH single domain antibodies are the best biologic alternative to therapeutic IgGs. Learn more about how the Isogenica LlamdA VHH library can accelerate your antibody discovery programmes. 

Download the infographic